Risk prediction models: II. External validation, model updating, and impact assessment
Karel G.M. Moons(University Medical Center Utrecht), Mark Woodward(UNSW Sydney), André Pascal Kengne(South African Medical Research Council), Diederick E. Grobbee(University Medical Center Utrecht), Douglas G. Altman(Unknown), Yvonne Vergouwe(Erasmus MC), Patrick Royston(Royal Statistical Society)
Cited by 1,188
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
|The Lancet|2010|4.2k
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations
|European Journal of Epidemiology|2016|3.1k
Evaluating non-randomised intervention studies
|Health Technology Assessment|2003|2.9k